ALG-LungCancerRegistry (SAFRO2202)

Recruiting now

Conditions studied: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Carcinoid Tumor

In brief

SAFRO 2202 ALG-Lung Cancer Registry is a prospective, multicenter, non-interventional observational study conducted across 21 public and university hospitals in Algeria. The objective is to characterize the epidemiological, clinical, pathological, molecular, and therapeutic features of patients diagnosed with lung cancer, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and carcinoid tumors. Eligible participants are adults aged 18 years or older, diagnosed at the time of inclusion or within the previous 12 months, and fully managed in oncology or pulmonology departments. Data are collected during routine clinical care and recorded in a secure electronic case report form (eCRF). No protocol-mandated interventions or study-specific visits are required. The study plans to enroll approximately 1,500 patients per year over a 30-month period. Primary outcomes include demographic and clinical profiles, tumor histology, molecular markers, staging at diagnosis, and treatment strategies (surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy). Secondary outcomes include treatment-related toxicities, objective response rate (ORR), progression-free survival (PFS), time to treatment discontinuation (TTD), and overall survival (OS). The findings from this registry will provide real-world evidence to support national health planning, improve lung cancer management, and guide future clinical and public health initiatives in Algeria.

Key facts

Study ID

NCT07161882

Run by

Société Algérienne de Formation et de Recherche en Oncologie

People needed

3750

Starts

2025-06-01

Expected to finish

2027-12-01

Last updated by the study team

2025-09-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Histologically confirmed diagnosis of lung cancer (NSCLC, SCLC, or carcinoid tumor)
• Diagnosed at the time of inclusion or within the 12 previous months
• Fully managed (diagnosis, treatment, and follow-up) in an oncology or pulmonology department of one of the 21 participating public/university hospitals
• Signed informed consent obtained

You may not qualify if…

• Prior enrollment in this study
• Participation in an interventional clinical trial

Where it is running

• Centre Pierre et Marie Curie — Algiers, Algiers Province, Algeria (enrolling)
• Chu Beni Messous - Isaad Hassani — Algiers, Algiers Province, Algeria (enrolling)
• CHU Mohamed Lamine Debaghine - Bab-el-Oued — Algiers, Algiers Province, Algeria (enrolling)
• Chu-Beni Messous - Isaad Hassani — Algiers, Algiers Province, Algeria (enrolling)
• EPH Rouiba — Algiers, Algiers Province, Algeria (enrolling)
• CLCC Annaba — Annaba, Annaba, Algeria (enrolling)
• CLCC Batna — Batna City, Batna, Algeria (enrolling)
• CAC-CHU Frantz Fanon — Blida, Blida Province, Algeria (enrolling)
• CHU- Hôpital Khelil Amrane — Béjaïa, Béjaia Province, Algeria (enrolling)
• CHU Dr Abdesselam Benbadis — Constantine, Constantine Province, Algeria (enrolling)
• EH Didouche Mourad — Constantine, Constantine Province, Algeria (enrolling)
• CLCC Draâ Ben Khedda — Tizi Ouzou, Draâ Ben Khedda, Algeria (enrolling)
• CAC-Laghouat — Laghouat, Laghouat Province, Algeria (enrolling)
• CAC Oran EL HASSI- EMIR ABDELKADER — Oran, Oran Province, Algeria (enrolling)
• CHU Dr. Benaouda Benzerdjeb — Oran, Oran Province, Algeria (enrolling)
• EHS 1er novembre — Oran, Oran Province, Algeria (enrolling)
• CAC- Ouargla — Ouargla, Ouargla Province, Algeria (enrolling)
• CAC El OUED — El Oued, Oued Souf, Algeria (enrolling)
• CAC- Sidi Bel Abbès — Sidi Bel Abbes, Sidi Bel Abbès Province, Algeria (enrolling)
• EPH- Sidi Ghiles — Tipasa, Sidi Ghiles, Algeria (enrolling)
• CAC-Sétif — Sétif, Sétif Province, Algeria (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.